The biopharmaceutical contract manufacturing market is projected to grow at a CAGR of 10% during 2022-2035, claims Roots Analysis
London, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “Biopharmaceutical Contract Manufacturing Market, 2022–2035” report to its list of offerings. In pursuit of both time and cost savings, as well as to access higher …